DEPARTMENTS | DIRECTORY | ADVANCED SEARCH | SCHOOL HOME
School Home NYU School of Medicine

irb
 Today is Friday, May 16th 2008
 
Available Forms:
Application for New Protocol Review
Supplements for Application for New Protocol Review
Exemption from IND/IDE Checklist

Application for Continuation

Application for Approval of Amendment
Application for Study_Personnel & Site Changes
Application for Exemption from Review
Application for Final Study Closure
Reportable Events Form
Application for The Emergency Use of Investigational Drug or Device
IRB Drop off Receipts
Application for
waiver of Authorization/Consent
 

IRB Forms

Revised Submission Instructions:

1. Application for New Protocol Review —submit this form for all new protocol submissions. Full board review deadlines are 21 days prior to corresponding meetings.

2. Application for Continuation—submit this form to renew your study each year approximately 90 days before the study expiration date. Please remember that if you are making any changes to your protocol and/or consent document during the continuation process, you will have to submit a request for approval of an amendment specifying all of the modifications to the consent and/or protocol including all of the additional required copies. This also pertains to conforming to the new standard consent/authorization consent template.

3. Application for Approval of Amendment-submit this form if your study requires any modifications or changes to the protocol or consent document.

4. Application for Exemption from Review-Submit this study for all new protocol submissions that meet the exempt category criteria. Click here to view the exempt categories

5. Application for Final Study Closure-submit this form to close your study.

6. Unanticipated Event Report Form-This form must accompany all Serious and Related SAE reports to the IRB.

7. Application for The Emergency Use of Investigational Drug or Device-An emergency is defined as a life-threatening situation in which no standard acceptable treatment is available and in which there is not sufficient time to obtain full IRB approval.

  • Submit an Application for Approval of Emergency Use to the IRB office.
  • Obtain written consent from the parents for use of the investigational drug or biological product in the child. This will require preparation of a consent form. The Emergency Use Consent Form developed by the IRB staff can be adapted, or you may be able to modify a sample consent form provided by the manufacturer of the IND.
  • Within five working days, provide a written report to the IRB that includes a description of the emergency situation, a description of the treatment outcome and a copy of the signed consent form. The FDA requires this report, which will be read into the minutes at the next regularly scheduled IRB meeting.

8. You should also download, complete and submit one of the new IRB "Drop-Off receipts" with each of your IRB submissions or responses to IRB findings. The IRB will stamp date these receipts only if hand delivered.

Download load forms using the links on the left of the page.


 

IRB Resources
HRPP Accreditation Tutorial
IRB Online Tutorials
IRB Online Tutorials Completion Search+Certificate Tool
IRB CITI Tutorials
Decision Charts -
Human Subject Regulations Decision Charts
IRB Newsletter
IRB Course Calendar
Policies and Procedures
HELP Downloading Forms
Lay Glossary
Useful Web Links
Sponsored Programs Administration (SPA)
Office of Clinical Trials (OCT)
Email a Suggestion or Comment to the IRB
Contact the IRB
GCRC Web Page
Instructions for Research Conducted at Bellevue
Printer-Friendly Version
Email this to a friend


Dept. Home | FAQs | IRB Forms | HIPAA Forms | Other Forms | Consent Templates | Info Sheets | Tool Kit | Schedule | Categories of Review | Policies | Glossary | Helpful Web Links | Multiple Project Assurance | Contact